Skip to main content
    C

    Clover Health Investments Corp (CLOV)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $4.68
    -0.11 (-2.30%)

    Market Cap: $2.54B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(17/24)
    Avg Surprise
    -10.69%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.01
    Range$0.01 - $0.01
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current$0.01
    Revenue Consensus
    $738M
    Range$728M - $744M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.01
    Range$0.01 - $0.01
    1 analysts
    Revenue Consensus
    $773M
    Range$757M - $783M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$0.01---
    Jun 26
    Reported Aug 5
    		$0.06$0.05+20.00%Beat+100.0%
    Mar 26
    Reported May 6
    		$0.07$0.07+0.00%Beat+40.0%
    Dec 25
    Reported Feb 26
    		$-0.10$-0.11+9.09%Beat-100.0%
    Sep 25
    Reported Nov 4
    		$-0.05$0.02-350.00%Miss-150.0%
    Jun 25
    Reported Aug 5
    		$0.03$0.03+0.00%Beat+50.0%
    Mar 25
    Reported May 6
    		$0.05$-0.07+171.43%Beat+200.0%
    Dec 24
    Reported Feb 27
    		$-0.05$-0.07+23.08%Beat+64.3%
    Sep 24
    Reported Nov 6
    		$-0.02$-0.03+33.33%Beat+75.0%
    Jun 24
    Reported Aug 5
    		$0.02$-0.04+150.00%Beat+140.0%
    Mar 24
    Reported May 7
    		$-0.05$-0.08+37.50%Beat+64.3%
    Dec 23
    Reported Mar 12
    		$-0.14$-0.14+0.00%Beat+17.6%
    Sep 23
    Reported Nov 6
    		$-0.08$-0.11+27.27%Beat+50.0%
    Jun 23
    Reported Aug 8
    		$-0.05N/A+61.54%Beat+77.3%
    Mar 23
    Reported May 9
    		$-0.14$-0.17+17.65%Beat+12.5%
    Dec 22
    Reported Feb 28
    		$-0.17$-0.26+34.62%Beat+39.3%
    Sep 22
    Reported Nov 7
    		$-0.16$-0.24+33.33%Beat-100.0%
    Jun 22
    Reported Aug 8
    		$-0.22$-0.20-10.00%Miss+71.8%
    Mar 22
    Reported May 9
    		$-0.16$-0.27+40.74%Beat-23.1%
    Dec 21
    Reported Feb 28
    		$-0.28$-0.26-7.69%Miss+85.3%
    Sep 21
    Reported Nov 9
    		$-0.08N/A+65.22%Beat-126.8%
    Jun 21
    Reported Aug 11
    		$-0.78$-0.14-457.14%Miss-362.8%
    Mar 21
    Reported May 17
    		$-0.13$-0.10-30.00%Miss+51.1%
    Dec 20
    Reported Jan 12
    		$-1.90$-0.84-126.19%Miss-614.3%
    Sep 20
    Reported Dec 2
    		$0.30$0.30-0.37%Miss+124.8%
    Jun 20
    Reported Aug 13
    		$0.30N/AN/ABeat+110.8%
    Mar 20
    Reported Jun 4
    		$-0.27$0.00N/AMiss+90.4%
    Dec 19
    Reported Mar 31
    		$-0.27$0.00N/AMiss-
    Jun 19
    Reported Sep 30
    		$-1.21$0.00N/AMiss-
    Mar 19
    Reported Jun 29
    		$-2.76$0.00N/AMiss-
    Dec 18
    Reported Mar 30
    		$-2.76$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-234.00EV/EBITDAN/A
    Price/FCF33.06xFCF Yield3.02%
    Profitability
    Profit Margin-0.74%Operating Margin3.77%
    ROE-5.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta2.46Avg Volume4.30M
    52-Week High$5.5952-Week Low$1.58

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.67
    SMA 20$4.55
    SMA 50$4.47
    SMA 200$3.43
    EMA 10$4.67
    EMA 20$4.60
    EMA 50$4.49
    EMA 200$3.81

    MACD

    Line: 0.08Signal: 0.05Hist: 0.03

    ADX

    ADX: 22.4+DI: 31.5-DI: 16.1

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down60.0
    PSAR$4.30

    Bollinger Bands

    Upper Band$4.91
    Lower Band$4.20
    %B Position1546%(Upper)
    Band Width0.68

    RSI (14-Day)

    Neutral
    54.7

    Momentum Oscillators

    Stoch %K59.1
    Stoch %D61.1
    Williams %R-48.2
    ROC (10d)10.6%
    Momentum0.45
    CCI (20d)61.3
    MFI (14d)48.8

    Volatility Measures

    ATR (14d)$0.23(4.8%)
    StdDev (20d)0.18
    Hist Vol41.0%(High)

    Volume Flow

    VWAP$4.68
    OBV-114.8M
    AD Line-127.9M
    CMF (20d)0.021

    Volume Metrics

    Avg Vol (20d)4.3M
    Vol Ratio0.8x
    VWMA (20d)$4.58

    Pivot Points

    R3$5.04
    R2$4.96
    R1$4.88
    Pivot Point$4.80
    S1$4.72
    S2$4.64
    S3$4.56

    Advanced Oscillators

    TSI10.98
    Ultimate Osc46.5
    KST43.72

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$743.17M$749.19M$487.71M$496.65M$477.62M$462.33M$336.50M$330.99M$356.26M$346.92M$307.66M$306.03M
    Cost of RevenueN/A$589.65M$413.50M$423.47M$377.99M$353.44M$243.04M$249.77M$248.35M$265.16M$447.99M$235.78M
    Gross ProfitN/A$159.54M$74.21M$73.18M$99.63M$108.89M$93.92M$81.21M$107.91M$81.76M$62.27M$70.24M
    Operating Expenses$715.17M$721.86M$537.03M$521.03M$488.18M$463.61M$358.41M$339.77M$349.07M$369.63M$375.52M$339.64M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$0$0$0$0$0$0$0$0$0$0$0$0
    Operating IncomeN/A$27.33M$-49,319,000$-24,377,000$-10,559,000$-1,274,000$-21,448,000$-8,785,000$7.19M$-22,703,000$-65,660,000$-33,616,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$1,000$0$0$0$0$0$0$0$0$0
    Income Before Tax$28.00M$27.33M$-49,319,000$-24,377,000$-10,559,000$-1,274,000$-21,915,000$-8,785,000$7.19M$-22,703,000$-67,859,000$-33,616,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$28.00M$27.33M$-49,320,000$-24,377,000$-10,578,000$-1,274,000$-22,092,000$-9,155,000$7.41M$-19,170,000$-70,472,000$-41,469,000
    EBITDA$28.14M$27.41M$-49,399,000$-24,367,000$-10,674,000$-1,245,000$-21,922,000$-8,968,000$6.57M$-23,056,000$-68,017,000$-34,302,000
    EBIT$28.00M$27.33M$-49,319,000$-24,377,000$-10,559,000$-1,274,000$-21,915,000$-8,785,000$7.19M$-22,703,000$-67,859,000$-33,616,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CLOV

    News

    Tax withholding prompts a proposed 14,341-share sale by Clover Health (CLOV) officer Karen M. Soares.

    Clover Health Investments, Corp. (CLOV) officer Karen M. Soares has proposed selling 14,341 shares of Class A common stock, valued at approximately $67,115.88. This non-discretionary sale...

    Stock Titan•10/15/26•Neutral

    To cover taxes, a Clover Health (CLOV) officer proposes selling 17,858 shares valued at $83.6K.

    Clover Health Investments, Corp. (CLOV) officer Jamie Reynoso plans to sell 17,858 shares of Class A common stock on October 15, 2026...

    Stock Titan•10/15/26•Neutral

    To cover taxes, Clover Health (CLOV) officer Andrew Toy proposes selling 60,765 shares.

    Clover Health officer Andrew Toy has proposed selling 60,765 Class A common shares worth approximately $284,380.2 on October 15...

    Stock Titan•10/15/26•Neutral

    Weekly Recap: 5.0/4.5 CMS 2027 star ratings and Q3 2026 results webcast

    Clover Health Investments Corp. (NASDAQ:CLOV) announced that its Medicare Advantage PPO plans received 5.0 stars and its HMO plans 4.5 stars for 2027 from CMS. This higher rating is expected to allow the company...

    TradingView•10/13/26•Bullish

    Under a trading plan, Jamie L. Reynoso sells Clover Health (CLOV) shares at $4.63 on average.

    Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health (CLOV), sold 2,006 shares of Class A common stock on October 7, 2026...

    Stock Titan•10/8/26•Neutral

    CLOV Valuation and Fair Value

    P/E
    -234.0x
    Forward P/E
    37.7x
    P/FCF
    33.1x
    P/B
    6.5x
    See GNG's fair value

    CLOV Profitability: Margins, ROIC and FCF

    Operating margin
    3.8%
    Net margin
    -0.7%
    ROE
    -5.1%
    FCF margin
    3.0%
    FCF yield
    3.0%

    CLOV Competitors

    CompanyTicker
    Guardian Pharmacy Services, Inc.GRDN
    Zai Lab LtdZLAB
    Nurix Therapeutics IncNRIX
    Sellas Life Sciences Group IncSLS
    TransMedics Group IncTMDX
    Beam Therapeutics IncBEAM
    Precigen IncPGEN
    Maravai Lifesciences Holdings IncMRVI

    Sector: Healthcare

    CLOV Analyst Ratings

    Consensus
    Hold
    Analysts
    3
    Strong Buy
    0
    Buy
    1
    Hold
    2
    Sell
    0
    Strong Sell
    0

    CLOV Bull Case vs Bear Case

    Bull case

    • CLOV grew quarterly revenue 55.6% year over year.

    Bear case

    • CLOV has a -0.7% net profit margin.

    CLOV Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -11.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.01
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About CLOV

    Does CLOV pay dividends?

    Clover Health Investments Corp (CLOV) does not currently pay a regular dividend.

    What is CLOV's market cap?

    Clover Health Investments Corp (CLOV) has a market capitalization of $2.54B with a current stock price of $4.68.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In